2014
DOI: 10.4102/jsava.v85i1.1041
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep

Abstract: Bluetongue (BT) is a non-contagious disease of sheep and other domestic and wild ruminants caused by the bluetongue virus (BTV). Currently 26 serotypes of the virus have been identified. In South Africa, 22 serotypes have been identified and BT is controlled mainly by annual vaccinations using a freeze-dried live attenuated polyvalent BTV vaccine. The vaccine is constituted of 15 BTV serotypes divided into three separate bottles and the aim is to develop a vaccine using fewer serotypes without compromising the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
3
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 12 publications
2
3
0
Order By: Relevance
“…The BTV-4 ELISA results obtained from the reference sera confirm the serotype relationships described by Erasmus in 1990 [ 30 ]. Figure 5 shows that the two reference sera for serotypes 10 and 20 cross-react the most with the BTV-4 ELISA.…”
Section: Discussionsupporting
confidence: 79%
“…The BTV-4 ELISA results obtained from the reference sera confirm the serotype relationships described by Erasmus in 1990 [ 30 ]. Figure 5 shows that the two reference sera for serotypes 10 and 20 cross-react the most with the BTV-4 ELISA.…”
Section: Discussionsupporting
confidence: 79%
“…Although in the current study, titration of antibodies was not done, the time taken for onset of neutralizing antibodies in BTV-16 superinfection was 15 days when compared to 7 days in BTV-4 infection and superinfection. As mentioned before, cross-neutralization of BTV-16 with BTV-4-specific neutralizing antibodies circulating in the superinfected animals is highly unlikely in this scenario as cross-protection conferred by BTV-4 which was experimentally confirmed for only BTV-9 and BTV-11 [30]. Furthermore, parallel studies in our laboratory suggested cross-neutralization of BTV-10 and not BTV-16 with BTV-4 serum.…”
Section: Discussionsupporting
confidence: 52%
“…Adoptive transfer experiments performed by Jeggo et al helped establish that BTV protection is likely mediated by a combination of humoral and cellular immunity [ 40 , 41 ]. Transfer of neutralizing antibodies is effective at preventing re-infection from the same serotype, but confer limited protection towards different ones [ 42 ]. Jeggo et al also showed that T cell adoptive transfer from BTV-recovered sheep protected from BTV challenge in monozygotic twins [ 41 ].…”
Section: The Control Of Btv By Host Immunitymentioning
confidence: 99%